HIGHLIGHTS
- who: TYPE and colleagues from the QEH, Hong Kong SAR, China Indira Gandhi National Tribal University have published the research: Editorial: Bioengineered nanoparticles in cancer therapy, Volume II, in the Journal: (JOURNAL) of 17/Oct/2022
- how: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
SUMMARY
Bioengineering, biomaterials, cancer therapy, nanoparticles, nanotechnology Editorial on the Research Topic Volume II: Bioengineered nanoparticles in cancer therapy Cancer is a typically rapidly progressing illness, which . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.